All the Active Ingredient Drugs
YORVIPATH
Neopharm (Israel) 1996 Ltd.
YORVIPATH
Parathyroid hormone analogue. palopegteriparatide 0.3 mg/ml. pre -filled pen2 X 1.4/0.56/0.98 ml sol for SC inj.
Starting dose is 18 mcg once /d with dose adjustments in 3 mcg increm. thereafter every 7 days. The dose range is 6 to 60 mcg/d. Serum calcium concentr. must be monitored during titrat. Mainten. dose should be dose that achieves serum calcium within normal range, without need for active vit D or therap. doses of calcium. See full prescr. info.
Parathyroid hne.(PTH) replacement ther. for adults with chronic hypoparathyroidism
C/I: Hypersens.- pseudohypoparathyroidism